2,149 research outputs found

    History, origins and importance of temporary ponds

    Get PDF
    In Europe, temporary ponds are a naturally common and widespread habitat occurring, often in abundance, in all biogeographical regions from the boreal snow-melt pools of northern Scandinavia to the seasonally inundated coastal dune pools of southern Spain. Ecological studies in Europe and elsewhere also emphasise that temporary ponds are a biologically important habitat type, renowned both for their specialised assemblages and the considerable numbers of rare and endemic species they support. They are, however, a habitat currently under considerable threat. Most temporary ponds are inherently shallow and the majority are destroyed even by limited soil drainage for agriculture or urban development. The paper gives an overview of definitions of temporary ponds and examines their formation and abundance. The authors also summarise a visit to the Bialowieza Forest in Poland to investigate the occurrence of temporary ponds

    Dangers and opportunities in managing temporary ponds

    Get PDF
    Although there is a growing awareness of the value of temporary ponds in Europe, there is still remarkably little information available to help guide their conservation and management. General principles which can be used to guide the management of temporary ponds as a whole have yet to be established. The aim of this article, therefore, is to give a broader overview of the main principles of temporary pond conservation, particularly by building on a number of general principles for managing ponds previously described by Biggs et al. (1994) and Williams et al. The authors emphasise the importance of surveys in order to get data on which to base management strategies. The main principles of temporary pond management are described, and examples of three case studies of ponds in England are given

    Precast Concrete Pavement Systems

    Get PDF
    Precast concrete pavement is becoming a favorable option to restore the functional and structural capacity of high-truck-volume traffic pavement. INDOT has a pilot project designed and constructed successfully in 2018. This session introduces the technology to practicing engineers

    Roles of Education and IQ in Cognitive Reserve in Parkinson's Disease-Mild Cognitive Impairment.

    Get PDF
    Background/aimsThe role of cognitive reserve in Parkinson's disease (PD)-mild cognitive impairment (MCI) is incompletely understood.MethodsThe relationships between PD-MCI, years of education, and estimated premorbid IQ were examined in 119 consecutive non-demented PD patients using logistic regression models.ResultsHigher education and IQ were associated with reduced odds of PD-MCI in univariate analysis. In multivariable analysis, a higher IQ was associated with a significantly decreased odds of PD-MCI, but education was not.ConclusionThe association of higher IQ and decreased odds of PD-MCI supports a role for cognitive reserve in PD, but further studies are needed to clarify the interaction of IQ and education and the impact of other contributors such as employment and hobbies

    Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial

    Get PDF
    BACKGROUND Depression is a common and costly comorbidity in dementia. There are very few data on the cost-effectiveness of antidepressants for depression in dementia and their effects on carer outcomes. AIMS To evaluate the cost-effectiveness of sertraline and mirtazapine compared with placebo for depression in dementia. METHOD A pragmatic, multicentre, randomised placebo-controlled trial with a parallel cost-effectiveness analysis (trial registration: ISRCTN88882979 and EudraCT 2006-000105-38). The primary cost-effectiveness analysis compared differences in treatment costs for patients receiving sertraline, mirtazapine or placebo with differences in effectiveness measured by the primary outcome, total Cornell Scale for Depression in Dementia (CSDD) score, over two time periods: 0-13 weeks and 0-39 weeks. The secondary evaluation was a cost-utility analysis using quality-adjusted life years (QALYs) computed from the Euro-Qual (EQ-5D) and societal weights over those same periods. RESULTS There were 339 participants randomised and 326 with costs data (111 placebo, 107 sertraline, 108 mirtazapine). For the primary outcome, decrease in depression, mirtazapine and sertraline were not cost-effective compared with placebo. However, examining secondary outcomes, the time spent by unpaid carers caring for participants in the mirtazapine group was almost half that for patients receiving placebo (6.74 v. 12.27 hours per week) or sertraline (6.74 v. 12.32 hours per week). Informal care costs over 39 weeks were £1510 and £1522 less for the mirtazapine group compared with placebo and sertraline respectively. CONCLUSIONS In terms of reducing depression, mirtazapine and sertraline were not cost-effective for treating depression in dementia. However, mirtazapine does appear likely to have been cost-effective if costing includes the impact on unpaid carers and with quality of life included in the outcome. Unpaid (family) carer costs were lower with mirtazapine than sertraline or placebo. This may have been mediated via the putative ability of mirtazapine to ameliorate sleep disturbances and anxiety. Given the priority and the potential value of supporting family carers of people with dementia, further research is warranted to investigate the potential of mirtazapine to help with behavioural and psychological symptoms in dementia and in supporting carers
    • …
    corecore